Effects of EGFR‐TKI on epidermal melanin unit integrity: Therapeutic implications for hypopigmented skin disorders
Pigment Cell & Melanoma Research · 2024
DOI: 10.1111/pcmr.13171 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, 2024. Verfasst von Ping Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pigmentation Research and Therapeutics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. Hauptthemen laut MEDLINE: ErbB Receptors, Hypopigmentation, Melanins, Protein Kinase Inhibitors. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Epidermal melanin unit integrity is crucial for skin homeostasis and pigmentation. Epidermal growth factor (EGF) receptor (EGFR) is a pivotal player in cell growth, wound healing, and maintaining skin homeostasis. However, its influence on skin pigmentation is relatively unexplored. This study investigates the impact and underlying mechanisms of EGFR inhibitors on skin pigmentation. We evaluated EGF and EGFR expression in various skin cells using quantitative real‐time PCR, Western blot, and immunofluorescence. EGF and EGFR were predominantly expressed in epidermal keratinocytes, and treatment with the EGFR tyrosine kinase inhibitors (EGFR‐TKIs) gefitinib and PD153035 significantly increased stem cell factor (SCF) and endothelin‐1 (ET‐1) expression in cultured keratinocytes. Enhanced melanocyte migration and proliferation were observed in co‐culture, as evidenced by time‐lapse live imaging and single‐cell tracking assays. Furthermore, topical application of gefitinib to guinea pig dorsal skin induced increased pigmentation and demonstrated efficacy in mitigating rhododendrol‐induced leukoderma. Suppression of EGF signaling indirectly enhanced skin pigmentation by upregulating SCF and ET‐1 in epidermal keratinocytes. This novel mechanism highlights the pivotal role of EGF signaling in regulating skin pigmentation, and topical EGFR‐TKI therapy at an appropriate dose may be a promising approach for depigmentation disorder management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pigmentation Research and Therapeutics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
- Department of Dermatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Biological Science Research Laboratories, Kao Corporation, Odawara, Japan.
- Department of Dermatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
ORCID-Profile: Lingli Yang, Yasutaka Kuroda
Zitieren
APA
Xu, P., Yang, L., Lai, S., Yang, F., Kuroda, Y., Zhang, H., Tsuruta, D., & Katayama, I. (2024). Effects of EGFR‐TKI on epidermal melanin unit integrity: Therapeutic implications for hypopigmented skin disorders. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13171
Vancouver
Xu P, Yang L, Lai S, Yang F, Kuroda Y, Zhang H, et al. Effects of EGFR‐TKI on epidermal melanin unit integrity: Therapeutic implications for hypopigmented skin disorders. Pigment Cell & Melanoma Research. 2024. doi:10.1111/pcmr.13171
BibTeX
@article{Xu2024,
author = {Xu, Ping and Yang, Lingli and Lai, Sylvia and Yang, Fei and Kuroda, Yasutaka and Zhang, Huimin and Tsuruta, Daisuke and Katayama, Ichiro},
title = {Effects of EGFR‐TKI on epidermal melanin unit integrity: Therapeutic implications for hypopigmented skin disorders},
journal = {Pigment Cell & Melanoma Research},
year = {2024},
doi = {10.1111/pcmr.13171}
}
EUVIMED